Anti-inflammatory effect of IDO1 inhibition for acute inflammation in the prostate

Anti-inflammatory effect of IDO1 inhibition for acute inflammation in the prostate

Bibliographic Details
Main Authors:	S. Ohira, S. Tone, S. Tsuji, H. Morinaka, N. Nishishita, H. Takasaki, K. Hirata, S. Sugiyama, M. Fujita, S. Tsukimori, S. Shimizu, M. Kaifu, R. Hara, T. Fujii, Y. Miyaji, A. Nagai
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320326987

Similar Items

Pathological analysis focused on inflammatory changes in bladder dysfunction following partial bladder outlet obstruction
by: H. Morinaka, et al.
Published: (2020-07-01)

New pathological subtype of renal cell carcinoma in patients on long-term dialysis: Acquired cystic disease-associated renal cell carcinoma
by: Y. Miyaji, et al.
Published: (2020-07-01)

Intra-abdominal desmoid tumor mimicking local recurrence of renal cell carcinoma after laparoscopic partial nephrectomy
by: Ryoei Hara, et al.
Published: (2019-05-01)

Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses
by: Lauren M. F. Merlo, et al.
Published: (2020-08-01)

IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity
by: Lauren M.F. Merlo, et al.
Published: (2016-11-01)

IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity
by: Lauren M.F. Merlo, et al.
Published: (2016-01-01)

Anti-inflammatory role of IDO and tryptophan metabolites
by: Salimi Elizei, Sanam
Published: (2016)

IDO2 in immunomodulation and autoimmunity
by: George ePrendergast, et al.
Published: (2014-11-01)

Soluble CD83 Triggers Resolution of Arthritis and Sustained Inflammation Control in IDO Dependent Manner
by: Dmytro Royzman, et al.
Published: (2019-04-01)

Pasture vegetation near the village of Iđoš
by: Knežević Aleksa S., et al.
Published: (2014-01-01)

Obesity, Inflammation, and Prostate Cancer
by: Kazutoshi Fujita, et al.
Published: (2019-02-01)

Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans
by: Valerio Napolioni, et al.
Published: (2019-05-01)

Aging-associated increase in indoleamine 2,3-dioxygenase (IDO) activity appears to be unrelated to the transcription of the IDO1 or IDO2 genes in peripheral blood mononuclear cells
by: Jylhä Marja, et al.
Published: (2011-10-01)

IDO and kynurenines in corneal allograft rejection
by: Zaher, Sarah Samir Abd-Elazim
Published: (2011)

IDO1 and IDO2 non-synonymous gene variants: correlation with crohn's disease risk and clinical phenotype.
by: Alexander Lee, et al.
Published: (2014-01-01)

The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.
by: Christiane A Opitz, et al.
Published: (2011-01-01)

Correction: IDO1 and IDO2 Non-Synonymous Gene Variants: Correlation with Crohn's Disease Risk and Clinical Phenotype.
by: Alexander Lee, et al.
Published: (2015-01-01)

Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG35-55-induced experimental autoimmune encephalomyelitis
by: Lisa A. Wetzel, et al.
Published: (2020-08-01)

¿Cómo ha ido evolucionando la revista?
by: María Carolina Cabrera Schulmeyer
Published: (2019-09-01)

IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
by: Yi-Shu Huang, et al.
Published: (2020-03-01)

Exploitation of the Ido Pathway in the Therapy of Rheumatoid Arthritis
by: Richard O. Williams
Published: (2013-07-01)

Exploitation of the IDO Pathway in the Therapy of Rheumatoid Arthritis
by: Richard O. Williams
Published: (2013-01-01)

IDO Targeting in Sarcoma: Biological and Clinical Implications
by: Imane Nafia, et al.
Published: (2020-03-01)

Immunological relevance of the coevolution of IDO1 and AHR
by: Francisco Javier Quintana, et al.
Published: (2014-10-01)

On the nonredundant roles of TDO2 and IDO1
by: Paolo ePuccetti
Published: (2014-10-01)

Trial watch: IDO inhibitors in cancer therapy
by: Julie Le Naour, et al.
Published: (2020-01-01)

Circulating Antibodies to IDO/THO Pathway Metabolites in Alzheimer's Disease
by: S. Duleu, et al.
Published: (2010-01-01)

IDO Expression in Cancer: Different Compartment, Different Functionality?
by: Annabel Meireson, et al.
Published: (2020-09-01)

The IDO Metabolic Trap Hypothesis for the Etiology of ME/CFS
by: Alex A. Kashi, et al.
Published: (2019-07-01)

New insights into IDO biology in bacterial and viral infections
by: Susanne Viktoria Schmidt, et al.
Published: (2014-08-01)

Synthesis of oxygen containing heterocycles as potential IDO inhibitors
by: Carvalho, Catarina
Published: (2013)

Current Challenges for IDO2 as Target in Cancer Immunotherapy
by: Giada Mondanelli, et al.
Published: (2021-04-01)

IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease
by: Robert Sucher, et al.
Published: (2010-01-01)

The philosophy of martial arts – the example of the concept of <i>Ido</i>
by: Wojciech J. Cynarski
Published: (2017-11-01)

IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease
by: Robert Sucher, et al.
Published: (2010-06-01)

Targeting the IDO1 pathway in cancer: from bench to bedside
by: Ming Liu, et al.
Published: (2018-08-01)

Aproximació a la partícula "idò", valors i melodies
by: Ignasi Mascaró
Published: (2014-02-01)

Cancer immunotherapy by targeting IDO1/TDO and their downstream effectors
by: Michael ePlatten, et al.
Published: (2015-01-01)

iDOS -- Triggering design inspiration on site with sketch media
by: Yi-Yen Wang, et al.
Published: (2010)

Parâmetros psicomotores e sociais em idos iron man
by: Coquerel, Patrick Ramon Stafin
Published: (2016)